Open AccessOncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Author(s) -
Haikuo Zhang,
Jun Qi,
Jaime M. Reyes,
Lewyn Li,
Prakash K. Rao,
Fugen Li,
Charles Y. Lin,
Jennifer A. Perry,
Matthew A. Lawlor,
Alexander Federation,
Thomas De Raedt,
Yvonne Y. Li,
Yan Liu,
Melissa Duarte,
Yanxi Zhang,
Grit S. Herter-Sprie,
Eiki Kikuchi,
Julián Carretero,
Charles M. Perou,
Jacob B. Reibel,
Joshiawa Paulk,
Roderick T. Bronson,
Hideo Watanabe,
Christine F. Brainson,
Carla F. Kim,
Peter S. Hammerman,
Myles Brown,
Karen Cichowski,
Henry W. Long,
James E. Bradner,
Kwok-Kin Wong
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/c0ws-ey78
Subject(s) - deregulation , lung cancer , ezh2 , targeted therapy , cancer , oncology , medicine , cancer research , biology , genetics , epigenetics , economics , gene , market economy